학술논문

SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome
Document Type
Journal
Source
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA; DEC 2022, 22 12, pE1059-pE1066, 8p.
Subject
Language
English
ISSN
21522669